FIRMQUARRYResearch workspace

EU_TED process · buyer country PRT · award

C/ BASE NO CPA SPMS 2025/1303 - TRASTUZUMAB DERUXTECANO 100 MG PÓ CONC SOL INJ FR IV

['Unidade Local de Saúde de Coimbra, EPE']

Procedure 63884d80-a757-4a0f-accd-c0b095ed7366CPV 33600000Healthcare
Not reported
Data last updated Oct 22, 2026 · Source: Tenders Electronic Daily
Buyer identifier
TED_ORGANISATION: 510103448
Procurement method
Not reported
Tender deadline
Not reported
Contract period
Not reported — Not reported
Native value
Not reported
USD comparison
Not shown — no auditable FX observation
Official source
Open notice ↗

Description

Aquisição de Trastuzumab deruxtecano 100 mg Pó conc sol inj Fr IV

Suppliers

Official lifecycle

Process timeline

  1. Award announced

    C/ BASE NO CPA SPMS 2025/1303 - TRASTUZUMAB DERUXTECANO 100 MG PÓ CONC SOL INJ FR IV

    PRT · eu_tedSource ↗

Notice versions

PublicationVersionTypeDateSource
757372-20261can-standardNov 2, 2026Official notice ↗ · XML ↗

Lots

LotCPVPerformanceNUTSValue
LOT-000033600000, 33600000PRTNot reportedNot reported

Contracts

ContractLotStatusPeriodValue
050104092026LOT-0000Not reportedNot reported — Not reportedNot reported

Auditable model output

Predictive intelligence

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Append-only source history

Source records

RecordDateStagesFetched
ad5c5171-568d-43c1-a65c-c98502da9454:1Nov 2, 2026award_announcedNov 3, 2026